 | Up a level |
Cross, AL, Hawkes, J, Wright, HL 
ORCID: 0000-0003-0442-3134, Moots, RJ ORCID: 0000-0001-7019-6211 and Edwards, SW ORCID: 0000-0002-7074-0552
(2020)
APPA (apocynin and paeonol) modulates pathological aspects of human neutrophil function, without supressing antimicrobial ability, and inhibits TNFα expression and signalling.
INFLAMMOPHARMACOLOGY, 28 (5).
pp. 1223-1235.
Zhao, S ORCID: 0000-0002-3558-7353, Otieno, F, Akpan, A ORCID: 0000-0002-1764-8669 and Moots, RJ ORCID: 0000-0001-7019-6211
(2017)
Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients.
Drugs and Aging, 34 (4).
pp. 255-264.
Fisher, BA, Everett, CC, Rout, J, O'Dywer, JL, Emery, P, Pitzalis, C, Ng, W-F, Carr, A, Pease, CT, Price, EJ et al (show 15 more authors)
(2017)
EFFECT OF RITUXIMAB ON A SALIVARY GLAND ULTRASOUND SCORE IN PRIMARY SJOGREN'S SYNDROME: RESULTS OF THE TRACTISS MULTICENTRE RANDOMISED TRIAL SUB-STUDY.
In: Annual European Congress of Rheumatology, 14–17 June, 2017.
Zhao, S ORCID: 0000-0002-3558-7353, Challoner, B, Khattak, M, Moots, RJ ORCID: 0000-0001-7019-6211 and Goodson, NJ ORCID: 0000-0003-0714-3568
(2017)
Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis.
Rheumatology international, 37 (2).
pp. 239-244.
Mitchell, TS, Moots, RJ ORCID: 0000-0001-7019-6211 and Wright, HL ORCID: 0000-0003-0442-3134
(2017)
Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 189 (2).
pp. 250-258.
Wright, HL ORCID: 0000-0003-0442-3134, Cox, T, Moots, RJ ORCID: 0000-0001-7019-6211 and Edwards, SW ORCID: 0000-0002-7074-0552
(2017)
Neutrophil biomarkers predict response to therapy with tumor necrosis factor inhibitors in rheumatoid arthritis.
Journal of Leukocyte Biology, 101 (3).
pp. 785-795.
Strand, V, Mysler, E, Moots, RJ ORCID: 0000-0001-7019-6211, Wallenstein, GV, Demasi, R, Gruben, D, Soma, K, Iikuni, N, Smolen, JS and Fleischmann, R
(2019)
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: A phase IIIB/IV trial.
RMD Open, 5 (2).
e001040-.
Glennon-Alty, L ORCID: 0000-0002-6416-0711, Moots, RJ ORCID: 0000-0001-7019-6211, Edwards, SW ORCID: 0000-0002-7074-0552 and Wright, HL ORCID: 0000-0003-0442-3134
(2021)
Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 203 (2).
pp. 151-159.